These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 36868290)

  • 1. Narirutin downregulates lipoxygenase-5 expression and induces G0/G1 arrest in triple-negative breast carcinoma cells.
    Singh S; Maurya AK; Meena A; Mishra N; Luqman S
    Biochim Biophys Acta Gen Subj; 2023 Jun; 1867(6):130340. PubMed ID: 36868290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narirutin. A flavonoid found in citrus fruits modulates cell cycle phases and inhibits the proliferation of hormone-refractory prostate cancer cells by targeting hyaluronidase.
    Singh S; Maurya AK; Meena A; Mishra N; Luqman S
    Food Chem Toxicol; 2023 Apr; 174():113638. PubMed ID: 36708865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neomenthol prevents the proliferation of skin cancer cells by restraining tubulin polymerization and hyaluronidase activity.
    Fatima K; Masood N; Ahmad Wani Z; Meena A; Luqman S
    J Adv Res; 2021 Dec; 34():93-107. PubMed ID: 35024183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of pharmacological agents for triple-negative breast cancer (TNBC): molecular docking and molecular dynamic simulation studies on 5-lipoxygenase (5-LOX) and nuclear factor kappa B (NF-κB).
    Kundu S; N S; T DAK
    J Biomol Struct Dyn; 2024 Oct; 42(17):9076-9089. PubMed ID: 37713334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrahydrofurandiol stimulation of phospholipase A2, lipoxygenase, and cyclooxygenase gene expression and MCF-7 human breast cancer cell proliferation.
    Markaverich BM; Crowley J; Rodriquez M; Shoulars K; Thompson T
    Environ Health Perspect; 2007 Dec; 115(12):1727-31. PubMed ID: 18087590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of Molecular Targets and Antiproliferative Effect of Citronellal on Triple-Negative Breast Cancer Cells.
    Fatima K; Luqman S
    Curr Mol Pharmacol; 2021; 14(6):1156-1166. PubMed ID: 33687907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin D inhibitors as potential therapeutics for breast cancer treatment: Molecular docking and bioevaluation against triple-negative and triple-positive breast cancers.
    Anantaraju HS; Battu MB; Viswanadha S; Sriram D; Yogeeswari P
    Mol Divers; 2016 May; 20(2):521-35. PubMed ID: 26563150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvacrol Arrests the Proliferation of Hypopharyngeal Carcinoma Cells by Suppressing Ornithine Decarboxylase and Hyaluronidase Activities.
    Fatima K; Luqman S; Meena A
    Front Nutr; 2022; 9():857256. PubMed ID: 35464036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Triple-Negative Breast Cancer Cell Aggressiveness by Cathepsin D Blockage: Role of Annexin A1.
    Zóia MAP; Azevedo FVP; Vecchi L; Mota STS; Rodovalho VR; Cordeiro AO; Correia LIV; Silva ACA; Ávila VMR; Araújo TG; Goulart LR
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Lox in triple-negative breast cancer.
    Leo C; Cotic C; Pomp V; Fink D; Varga Z
    Ann Diagn Pathol; 2018 Jun; 34():98-102. PubMed ID: 29661738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propolin G-Suppressed Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells via Glycogen Synthase Kinase 3β-Mediated Snail and HDAC6-Regulated Vimentin Degradation.
    Pai JT; Chen XH; Leu YL; Weng MS
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase.
    Li L; Zeng H; Shan L; Yuan X; Li Y; Liu R; Zhang W
    J Ethnopharmacol; 2012 Sep; 143(2):732-9. PubMed ID: 22884869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myricetin 3-rhamnoside retards the proliferation of hormone-independent breast cancer cells by targeting hyaluronidase.
    Singh S; Maurya AK; Meena A; Mishra N; Luqman S
    J Biomol Struct Dyn; 2024; 42(19):10311-10322. PubMed ID: 37732353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycemic conditions proliferate triple negative breast cancer cells: role of ornithine decarboxylase.
    Capellen CC; Ortega-Rodas J; Morwitzer MJ; Tofilau HMN; Dunworth M; Casero RA; Chandra S
    Breast Cancer Res Treat; 2021 Nov; 190(2):255-264. PubMed ID: 34529197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XS-2, a novel potent dual PI3K/mTOR inhibitor, exhibits high in vitro and in vivo anti-breast cancer activity and low toxicity with the potential to inhibit the invasion and migration of triple-negative breast cancer.
    Xu S; Sun X; Luo L; Yang Y; Guo Q; Tang S; Jiang Z; Li Y; Han J; Gan W; Yang F; Zhang X; Liu Y; Sun C; He J; Liu M; Zuo D; Zhu W; Wu Y
    Biomed Pharmacother; 2022 Nov; 155():113537. PubMed ID: 36113258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
    Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
    J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1.
    Cınar V; Hamurcu Z; Guler A; Nurdinov N; Ozpolat B
    Breast Cancer; 2022 Nov; 29(6):1106-1120. PubMed ID: 36006564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective multifunctional roles and pharmacological potential of dietary flavonoid narirutin.
    Mitra S; Lami MS; Uddin TM; Das R; Islam F; Anjum J; Hossain MJ; Emran TB
    Biomed Pharmacother; 2022 Jun; 150():112932. PubMed ID: 35413599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ornithine decarboxylase in regulation of estrogen receptor alpha expression and growth in human breast cancer cells.
    Zhu Q; Jin L; Casero RA; Davidson NE; Huang Y
    Breast Cancer Res Treat; 2012 Nov; 136(1):57-66. PubMed ID: 22976807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sophoraflavanone G suppresses the progression of triple-negative breast cancer via the inactivation of EGFR-PI3K-AKT signaling.
    Cheng W; Liu D; Guo M; Li H; Wang Q
    Drug Dev Res; 2022 Aug; 83(5):1138-1151. PubMed ID: 35426453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.